September 25, 2018

Leveraging 3DP Technologies to Accelerate Time to Market

Aprecia CEO, Dr. Tim Tracy, will be speaking at the 3rd annual Fierce Biotech Drug Development Forum, October 1 - 3 in Boston, MA. Join Dr. Tracy and other distinguished speakers who will examine breakthroughs in guiding early stage research.

Tuesday, October 2, 2018 at 4:40 PM

Register Now for Dr. Tracy's session.

Overview

A novel manufacturing process using three-dimensional printing has been developed to meet the needs of various individual or combined formulation challenges. The dosage form is assembled layer-by-layer without using compression forces or traditional molding techniques. Prior to commercial medication manufacturing, 3DP also offers application in pre-clinical and clinical trial stages that translate more quickly to final product scale, bringing significant business advantages to your bottom line.

Speaking topics include:

·      Novel dosage forms to minimize R&D iterations of dosing frequency and dose size

·      New technologies to produce first in-human dosage forms

·      Providing real-time formulation support for adaptive clinical trials

·      Non-compression tableting methods to accommodate fragile molecules and particles